No Login Data Private Local Save

Opioid Equianalgesic Calculator – Morphine Milligram Equivalents

68
0
0
0

Opioid Equianalgesic Calculator

Calculate Morphine Milligram Equivalents (MME) for safe opioid prescribing

Based on CDC Guidelines for Prescribing Opioids

Total Daily MME
—
05090150+
Enter doses to calculate
CDC Risk Categories
Low Risk
< 50 MME/day

Recommended range for most patients initiating opioid therapy

Moderate Risk
50 – 90 MME/day

Requires careful monitoring; weigh benefits vs. risks

High Risk
≥ 90 MME/day

Avoid without strong clinical justification; increased overdose risk

Frequently Asked Questions

MME (Morphine Milligram Equivalent) is a standardized measure used to compare the potency of different opioid medications. It converts any opioid dose into the equivalent analgesic dose of oral morphine. This allows healthcare providers to assess the total opioid burden a patient is receiving, regardless of which specific opioid medications are prescribed. MME is essential for evaluating overdose risk, guiding opioid tapering, and ensuring patient safety.

Each opioid has a specific conversion factor relative to oral morphine. For example, oxycodone is approximately 1.5 times more potent than morphine (1 mg oxycodone ≈ 1.5 MME), while hydromorphone is about 4 times more potent (1 mg hydromorphone ≈ 4 MME). Codeine is less potent, with 1 mg codeine ≈ 0.15 MME. The route of administration also matters—intravenous morphine is roughly 3 times more potent than oral morphine. Fentanyl transdermal patches use a different calculation: 1 mcg/hr ≈ 2.4 MME/day.

The CDC's 2016 guidelines established MME thresholds to guide safe opioid prescribing: less than 50 MME/day is considered low risk for most patients; 50–90 MME/day represents moderate risk requiring careful monitoring; and 90 MME/day or greater is considered high risk and should be avoided without strong clinical justification. The 2022 updated guidelines maintain that doses ≥90 MME/day require particularly strong justification and close monitoring due to significantly increased overdose risk.

Calculating total daily MME helps clinicians identify patients at elevated risk of opioid overdose and opioid use disorder. Research shows that the risk of fatal opioid overdose approximately doubles at 50–90 MME/day and increases further at doses ≥90 MME/day compared to doses below 20 MME/day. The MME calculator supports clinical decision-making for opioid rotation, tapering, and de-escalation. It also aids in identifying patients who may benefit from naloxone co-prescribing for overdose prevention.

Route of administration significantly impacts opioid potency due to differences in bioavailability. Oral morphine has approximately 30% bioavailability, while intravenous morphine is 100% bioavailable, making IV morphine roughly 3 times more potent. Similarly, oral hydromorphone has a conversion factor of 4, while IV hydromorphone has a factor of about 20. Transdermal fentanyl bypasses first-pass metabolism and provides continuous delivery, with 1 mcg/hr approximately equating to 2.4 MME/day. Always consider the route when calculating MME.

Methadone has a unique and complex MME conversion because its potency increases disproportionately at higher doses due to its long half-life and NMDA receptor antagonism. The conversion factor is dose-dependent: for methadone doses of 1–20 mg/day, the factor is approximately 4; for 21–40 mg/day, approximately 8; for 41–60 mg/day, approximately 10; and for doses above 60 mg/day, the factor may be 12 or higher. This non-linear relationship makes methadone particularly challenging to convert accurately, and specialist consultation is recommended.

For transdermal fentanyl, 1 mcg/hr is approximately equivalent to 2.4 MME/day. For example, a 25 mcg/hr fentanyl patch equates to roughly 60 MME/day, and a 50 mcg/hr patch equates to roughly 120 MME/day. For intravenous fentanyl, the conversion is much higher—approximately 100 MME per 1 mg of IV fentanyl (or 0.1 MME per 1 mcg). Always use caution when converting between fentanyl and other opioids due to fentanyl's extreme potency.

Yes, this MME calculator is a valuable tool for opioid tapering. By understanding the total MME, clinicians can plan gradual dose reductions—typically 5–10% per week or month depending on the clinical situation. The CDC recommends that tapering should be individualized and conducted at a pace the patient can tolerate. Abrupt discontinuation or overly rapid tapering can lead to withdrawal symptoms, increased pain, and psychological distress. Always develop a patient-centered tapering plan with shared decision-making.

MME conversions provide estimates based on population averages and may not perfectly reflect individual patient responses. Factors such as genetics (CYP450 enzyme variants), age, liver and kidney function, drug interactions, opioid tolerance, and the specific clinical context all influence actual opioid potency. Incomplete cross-tolerance means that when switching between opioids, the new opioid may be more potent than the conversion factor suggests. CDC recommends reducing the calculated equianalgesic dose by 25–50% when rotating opioids to account for incomplete cross-tolerance.

Disclaimer: This calculator provides estimated conversions based on CDC guidelines and published equianalgesic data. It is for educational and reference purposes only. Clinical judgment should always guide opioid prescribing decisions. Conversions may vary based on individual patient factors. Consult current guidelines and specialist resources when managing complex cases.